Form 4: Myriad Genetics Director Heinrich Dreismann Sells 10,000 Shares

Director Heinrich Dreismann sold 10,000 shares of Myriad Genetics Inc. on September 9, 2024, at an average price of $27.052 per share.

Summary

• On September 9, 2024, Heinrich Dreismann, a director of Myriad Genetics Inc. (MYGN), sold 10,000 shares of common stock.
• The sale was executed at a weighted average price of $27.052 per share, with individual transactions ranging from $27.02 to $27.13.
• Following the transaction, Dreismann directly owns 121,648 shares of Myriad Genetics Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a sale of shares by a company director. It doesn't inherently convey positive or negative sentiment, but rather reports a transaction. The sentiment is neutral.

Industry Context

This transaction is a routine disclosure of insider trading activity. It's important to monitor such filings to understand the sentiment of company insiders regarding the stock's valuation and future prospects.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, potentially leading to a slight decrease in stock price, although the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates